Evidence map›Paper›PMID 24595047›Full record

Trial reportThe Pediatric infectious disease journal2014

White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy.

Christelle Ackermann, Savvas Andronikou, Barbara Laughton, Martin Kidd, Els Dobbels, Steve Innes, Ronald van Toorn, Mark Cotton

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Pediatric infectious disease journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Brain MRI and neurocognitive characteristics of children and adolescents living with HIV.Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Christelle AckermannFrom the *Department of Radiology, Stellenbosch University, Tygerberg; †Department of Radiology, University of Witwatersrand, Johannesburg, Gauteng; ‡Children's Infectious Diseases Clinical Research Unit, Stellenbosch University; §Tygerberg Children's Hospital; ¶Centre for Statistical Consultation and ‖Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, Cape Town, South Africa.
Savvas Andronikou
Barbara Laughton
Martin Kidd
Els Dobbels
Steve Innes
Ronald van Toorn
Mark Cotton
Tygerberg Children’s Hospital · ZAStellenbosch University · ZAStatistical Service · CYUniversity of the Witwatersrand · ZA

Funding

The effect of ART on rates and transmission of TBU19AI053217 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI MCINTYRE, JAMES ALASDAIR · 2002 to 2011
$44.9M
NIAID NIH HHS U19 AI053217PHS HHS U19A153217
6 · The paper itself

Abstract

backgroundThe natural history and manifestation of HIV-related neurologic disease have been ameliorated by combination antiretroviral therapy (ART). We describe the characteristics of white matter signal abnormalities (WMSA) on magnetic resonance imaging in children with HIV-related neurologic disease.

methodsWe reviewed magnetic resonance imaging scans of children with suspected HIV-related neurologic disease despite early ART and correlated with clinical, neurodevelopmental data, virologic markers and time on ART. These children were also on the Children with HIV Early Antiretroviral (CHER) trial.

resultsMagnetic resonance imaging scans were performed at a mean age 31.9 months (range 8-54) on 44 children: 10 on deferred and 34 on early treatment arms, commencing ART at mean age of 18.5 and 8 weeks, respectively. Multiple high signal intensity lesions on T2/fluid attenuated inversion recovery were documented in 22 patients (50%), predominantly in frontal (91%) and parietal (82%) white matter. No differences in neurodevelopmental scores comparing children with and without WMSA were found. Neither lesion load nor distribution showed significant correlation with neurodevelopmental scores or neurologic examination. Normal head growth was more common in the WMSA group (P = 0.01). There was a trend for association of WMSA and longer time on ART (P = 0.13) and nadir CD4% (P = 0.08).

conclusionsHalf of children referred with HIV-related brain disease had WMSA on T2/fluid attenuated inversion recovery. Our findings of the association with normal head growth and duration of ART require further study. We suspect that WMSA can occur early and that initiating ART by 8 weeks of life may be too late to prevent HIV from entering the central nervous system.

Indexed as

AIDS Dementia ComplexAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBrainChild, PreschoolFemaleHIV InfectionsHumansInfantLeukoencephalopathiesMagnetic Resonance ImagingMaleProspective StudiesSouth AfricaAnti-Retroviral Agents

Identifiers

PMID24595047
PMCPMC4153800
OpenAlexW2329802697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.